Nutzen von PROMs für die klinische Praxis
Unterstützung der klinischen Therapie- und Versorgungsprozesse (2)
Given their benefits, many organisations and guidelines recommend integrating PROMs into routine cancer care, e.g.:
| Name der Leitlinie | Jahr | Herausgebende Organisation |
|---|---|---|
| Management of Dyspnoea in Advanced Cancer (link) | 2021 | National Comprehensive Cancer Network (NCCN) |
| The role of patient-reported outcome measures in the continuum of cancer clinical care (link) | 2022 | European Society for Medical Oncology (ESMO) |
| Distress Management (link) | 2019 | American Society of Clinical Oncology (ASCO) |
| EORTC Quality of Life Group Manual for the use of EORTC measures in daily clinical practice (link) | 2016 | European Organisation for Research and Treatment of Cancer (EORTC) |
| User’s Guide to Implementing Patient-Reported Outcomes Assessment in Clinical Practice (link) | 2015 | International Society for Quality of Life Research (ISOQOL) |